Empreendimentos Pague Menos (PGMN3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 Jul, 2026Executive summary
Achieved 14.4% year-over-year revenue growth in Q1 2026, with same-store sales up 13% and national market share rising to 6.7%, led by strong gains in the North and Northeast regions.
Adjusted EBITDA grew 36.1% year-over-year to R$204.7 million, marking the seventh consecutive quarter of 30%+ growth.
Net income reached R$55.6 million, more than quadrupling from Q1 2025, with net margin expanding by 0.9 percentage points.
Digital channels accounted for 22.2% of sales, up 4.6 percentage points year-over-year, with omnichannel sales up 43.7%.
Continuous care customers now represent 28% of the base, with increased purchase frequency and average ticket.
Financial highlights
Gross revenue reached R$4.14 billion (+14.4% YoY); gross profit was R$1.22 billion (+17.2% YoY); gross margin expanded to 29.5% (+0.8p.p. YoY).
Adjusted EBITDA margin reached 4.9% in Q1, up 0.8 percentage points year-over-year.
Adjusted net income margin was 1.3% (+0.9p.p. YoY); earnings per share hit an all-time high of R$0.50 (LTM).
Net debt/EBITDA improved to 1.9x, down 0.9x year-over-year, reflecting deleveraging.
ROIC reached 21.2%, up 6.8 percentage points over two years.
Outlook and guidance
Pipeline of new stores supports gradual acceleration of organic growth for the remainder of the year.
Continued focus on digital expansion, continuous care customer engagement, and operational efficiency expected to drive further margin and profitability gains.
Gross margin for the full year expected to be slightly lower than 2025, but EBITDA margin improvement remains a focus.
Anticipate positive impact on margins from the new Paraíba distribution center starting Q3 2026.
Under-development projects include new store models, pricing policies, and private label reinvention.
Latest events from Empreendimentos Pague Menos
- Revenue and profit surged as growth accelerated, cash flow improved, and market share increased.PGMN3
Q2 202415 Jul 2026 - Record sales, margin gains, and cash flow driven by Extrafarma synergies and digital growth.PGMN3
Q3 202415 Jul 2026 - Record revenue, EBITDA, and digital sales drove margin gains and market share growth in 1Q25.PGMN3
Q1 202515 Jul 2026 - Record sales and digital growth drove higher margins, profit, and market share gains.PGMN3
Q2 202515 Jul 2026 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 202515 Jul 2026 - 2025 saw record revenue, EBITDA, and net income, with market share and digital sales at all-time highs.PGMN3
Q4 20257 Jul 2026 - Record sales, margin expansion, and synergy gains drive robust growth and deleveraging.PGMN3
Q4 20242 Jul 2026 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation3 Jul 2025 - Nationwide Health Hub and digital innovation fuel PagueMenos extrafarma’s rapid, profitable growth.PGMN3
Investor Presentation16 Jun 2025